Many reports place PIC market growth at a CAGR1 of over 20% until 2025 and even beyond. Because of this, superior automation for both assembly and testing is critical in enabling high-volume ...
RARITAN, N.J., March 23, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received authorization ...
Roche announced today that its new, dedicated high-volume testing immunoassay solution for the cobas 8000 modular analyzer series, the cobas e 801 module, has received 510(k) clearance from the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback